PMID: 16696816

Floreani A, Carderi I, Paternoster D, Soardo G, Azzaroli F, Esposito W, Variola A, Tommasi AM, Marchesoni D, Braghin C, Mazzella G
Intrahepatic cholestasis of pregnancy: three novel MDR3 gene mutations.
Aliment Pharmacol Ther. 2006 Jun 1;23(11):1649-53., [PubMed]
Sentences
No. Mutations Sentence Comment
6 ABCB4 p.Glu528Asp
X
ABCB4 p.Glu528Asp 16696816:6:85
status: NEW
view ABCB4 p.Glu528Asp details
ABCB4 p.Arg549His
X
ABCB4 p.Arg549His 16696816:6:92
status: NEW
view ABCB4 p.Arg549His details
ABCB4 p.Gly536Arg
X
ABCB4 p.Gly536Arg 16696816:6:99
status: NEW
view ABCB4 p.Gly536Arg details
Results Three novel non-synonymous heterozygous mutations in exon 14 were found (4%; E528D, R549H, G536R) among the 80 intrahepatic cholestasis of pregnancy patients, whereas the pregnant controls were all negative for exon 14 polymorphisms. Login to comment
35 ABCB4 p.Ser320Phe
X
ABCB4 p.Ser320Phe 16696816:35:185
status: NEW
view ABCB4 p.Ser320Phe details
ABCB4 p.Gly535Asp
X
ABCB4 p.Gly535Asp 16696816:35:237
status: NEW
view ABCB4 p.Gly535Asp details
ABCB4 p.Ala546Asp
X
ABCB4 p.Ala546Asp 16696816:35:272
status: NEW
view ABCB4 p.Ala546Asp details
ABCB4 p.Arg957*
X
ABCB4 p.Arg957* 16696816:35:389
status: NEW
view ABCB4 p.Arg957* details
ABCB4 p.Gly762Glu
X
ABCB4 p.Gly762Glu 16696816:35:348
status: NEW
view ABCB4 p.Gly762Glu details
ABCB4 p.Arg150Lys
X
ABCB4 p.Arg150Lys 16696816:35:108
status: NEW
view ABCB4 p.Arg150Lys details
ABCB4 p.Arg144*
X
ABCB4 p.Arg144* 16696816:35:75
status: NEW
view ABCB4 p.Arg144* details
MDR3 mutations reported in the literature Mutation (codon) Exon Reference (R144X) 6 Gendrot et al.5 481G>A (R150K) 6 Mu¨llenbach et al.6 426-432del (132) 6 DeVree et al.13 959C>T (S320F) 9 Rosmordurc et al.,14 Pauli-Magnus et al.9 (G535D) 14 Lucena et al.7 1669 C>A (A546D) 14 Dixon et al.4 1712 del T (571) 14 Jacquemin et al.8, 15 2285 G>A (G762E) 18 Pauli-Magnus et al.9 2901 C>T (R957X) 23 DeVree et al.13 conditions included an initial denaturation step at 94 °C for 5 min, followed by 40 cycles of denaturation at 94 °C for 30 s, annealing at 55 °C for 30 s and extension at 72 °C for 30 s. Login to comment
51 ABCB4 p.Gly536Arg
X
ABCB4 p.Gly536Arg 16696816:51:140
status: NEW
view ABCB4 p.Gly536Arg details
Patient #3 had a heterozygous mutation (GGG-AGG) in codon 536 with a consequent substitution of the wild-type glycine with mutant arginine (G536R). Login to comment
68 ABCB4 p.Gly536Arg
X
ABCB4 p.Gly536Arg 16696816:68:248
status: NEW
view ABCB4 p.Gly536Arg details
ATP-binding and hydrolysis are mediated by NBDs, which are characterized as in all ABC transporters, by three consensus motifs: the Walker A, Walker B and a linker region (ABC signature dodecapeptide) just upstream from the Walker B domain).10 The G536R mutation is located in the linker region of the NBD1. Login to comment
69 ABCB4 p.Glu528Asp
X
ABCB4 p.Glu528Asp 16696816:69:4
status: NEW
view ABCB4 p.Glu528Asp details
The E528D mutation is located in the central part of the NBD1, close to the linker region. Login to comment
70 ABCB4 p.Arg549His
X
ABCB4 p.Arg549His 16696816:70:4
status: NEW
view ABCB4 p.Arg549His details
The R549H mutation is located between the linker region and the Walker B domain. Login to comment
72 ABCB4 p.Glu528Asp
X
ABCB4 p.Glu528Asp 16696816:72:11
status: NEW
view ABCB4 p.Glu528Asp details
ABCB4 p.Arg549His
X
ABCB4 p.Arg549His 16696816:72:63
status: NEW
view ABCB4 p.Arg549His details
ABCB4 p.Gly536Arg
X
ABCB4 p.Gly536Arg 16696816:72:37
status: NEW
view ABCB4 p.Gly536Arg details
Patient #1 E528D mutation Patient #3 G536R mutation Patient #2 R549H mutation Figure 1. Login to comment
75 ABCB4 p.Glu528Asp
X
ABCB4 p.Glu528Asp 16696816:75:72
status: NEW
view ABCB4 p.Glu528Asp details
ABCB4 p.Arg549His
X
ABCB4 p.Arg549His 16696816:75:89
status: NEW
view ABCB4 p.Arg549His details
ABCB4 p.Gly536Arg
X
ABCB4 p.Gly536Arg 16696816:75:106
status: NEW
view ABCB4 p.Gly536Arg details
Clinical details of ICP patients with heterozygous mutations Patient #1 E528D Patient #2 R549H Patient #3 G536R Onset of pruritus 3rd trimester 3rd trimester 3rd trimester Parity 0002 0001 0001 Previous ICP No Yes Yes Peak of AST (U/L) 163 88 129 Peak of ALT (U/L) 98 121 137 Bilirubin (mg/dL) 0.60 0.61 0.89 Peak of GGT (U/L) 8 15 19 Cholesterol lithiasis No Yes No Total bile salts (lM/L) 3.3 6.3 10.1 Delivery Vaginal Vaginal Caesarean ICP, intrahepatic cholestasis of pregnancy; AST, aspartate aminotransferase; ALT, alanine aminotransferase. A drawback of our study lies is not having sequenced the whole MDR3 gene, as our study design only involved sequencing exon 14; may also consequently underestimate the real prevalence of MDR3 mutations in ICP patients. Login to comment